These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9865743)
21. Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance. Catto JW; Hartmann A; Stoehr R; Bolderson E; Rehman I; Rosario DJ; Hamdy FC; Meuth M J Urol; 2006 Jun; 175(6):2323-30. PubMed ID: 16697867 [TBL] [Abstract][Full Text] [Related]
22. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Hafner C; Knuechel R; Stoehr R; Hartmann A Int J Cancer; 2002 Sep; 101(1):1-6. PubMed ID: 12209580 [TBL] [Abstract][Full Text] [Related]
23. Multiple head and neck tumors: evidence for a common clonal origin. Bedi GC; Westra WH; Gabrielson E; Koch W; Sidransky D Cancer Res; 1996 Jun; 56(11):2484-7. PubMed ID: 8653681 [TBL] [Abstract][Full Text] [Related]
24. A molecular genetic and statistical approach for the diagnosis of dual-site cancers. Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033 [TBL] [Abstract][Full Text] [Related]
25. Partial allelotype of carcinoma in situ of the human bladder. Rosin MP; Cairns P; Epstein JI; Schoenberg MP; Sidransky D Cancer Res; 1995 Nov; 55(22):5213-6. PubMed ID: 7585577 [TBL] [Abstract][Full Text] [Related]
26. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Orlow I; Lianes P; Lacombe L; Dalbagni G; Reuter VE; Cordon-Cardo C Cancer Res; 1994 Jun; 54(11):2848-51. PubMed ID: 8187066 [TBL] [Abstract][Full Text] [Related]
27. High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers. Kawanishi H; Takahashi T; Ito M; Watanabe J; Higashi S; Kamoto T; Habuchi T; Kadowaki T; Tsujimoto G; Nishiyama H; Ogawa O Cancer Sci; 2006 Aug; 97(8):746-52. PubMed ID: 16863508 [TBL] [Abstract][Full Text] [Related]
28. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Fujii H; Yoshida M; Gong ZX; Matsumoto T; Hamano Y; Fukunaga M; Hruban RH; Gabrielson E; Shirai T Cancer Res; 2000 Jan; 60(1):114-20. PubMed ID: 10646862 [TBL] [Abstract][Full Text] [Related]
29. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063 [TBL] [Abstract][Full Text] [Related]
30. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas. McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846 [TBL] [Abstract][Full Text] [Related]
31. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Califano J; Leong PL; Koch WM; Eisenberger CF; Sidransky D; Westra WH Clin Cancer Res; 1999 Jul; 5(7):1862-7. PubMed ID: 10430093 [TBL] [Abstract][Full Text] [Related]
33. The random development of LOH on chromosome 9q in superficial bladder cancers. van Tilborg AA; de Vries A; de Bont M; Groenfeld LE; Zwarthoff EC J Pathol; 2002 Nov; 198(3):352-8. PubMed ID: 12375268 [TBL] [Abstract][Full Text] [Related]
34. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality. Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360 [TBL] [Abstract][Full Text] [Related]
35. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31. Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930 [TBL] [Abstract][Full Text] [Related]
36. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124 [TBL] [Abstract][Full Text] [Related]
37. Synchronous oral carcinomas: independent or common clonal origin? Scholes AG; Woolgar JA; Boyle MA; Brown JS; Vaughan ED; Hart CA; Jones AS; Field JK Cancer Res; 1998 May; 58(9):2003-6. PubMed ID: 9581845 [TBL] [Abstract][Full Text] [Related]
38. Molecular clonal analysis of recurrent bladder cancer. Junker K; Wolf M; Schubert J Oncol Rep; 2005 Aug; 14(2):319-23. PubMed ID: 16012709 [TBL] [Abstract][Full Text] [Related]
39. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder. Turyn J; Matuszewski M; Schlichtholz B Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066 [TBL] [Abstract][Full Text] [Related]
40. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]